menu search

Avid Bioservices Reports Financial Results for Fourth Quarter and Fiscal Year Ended April 30, 2023

Avid Bioservices Reports Financial Results for Fourth Quarter and Fiscal Year Ended April 30, 2023
— Fourth Quarter and Full Year Revenue of $39.8 Million and $149.3 Million, Respectively, Both Represent a Record-High Achievement — — Signed $55 Million in Net New Business Orders Resulting in a Record-High Backlog of $191 Million — — Mammalian Cell Manufacturing and Process Development Facility Expansions Currently Online and Active, Adding Approximately $120 Million […] The post Avid Bioservices Reports Financial Results for Fourth Quarter and Fiscal Year Ended April 30, 2023 appeared first o... Read More
Posted: Jun 21 2023, 20:07
Author Name: forextv
Views: 081176

Search within

Pages Search Results: